Most (25% strong positive;67% moderate positive) of primary tumor samples displayed a positive IHC staining for RBM7, whereas most of lung/liver metastatic lesions showed weak or negative RBM7 expression (Figure 1G). The gene discussed is RBM7; the disease is neoplasm.